Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04843371 · ClinicalTrials.gov registry record
PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
A clinical trial of Cardiomyopathies and Valvular Heart Disease, sponsored by Tulane University.
- Recruiting
- Registry status
- 500
- Enrollment target
- 3
- Study locations
NCT04843371: Recruiting study of Cardiomyopathies and Valvular Heart Disease, sponsored by Tulane University.
NCT04843371 is a study of Cardiomyopathies and Valvular Heart Disease that is actively recruiting participants, run by Tulane University. The registered enrollment target is 500 participants, below the 606-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (17% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04843371, a study of Cardiomyopathies and Valvular Heart Disease, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 3
- Study locations
Study Summary
The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signals obtained from PPG in the general population. Finally, the investigators are also aiming to investigate the association between signals obtained from PPG in the general population to cardioechographic findings such as, valvular heart disease, structural heart diseases, cardiomyopathies, pericardial disease etc.
Primary Outcome
Patients who will undergo echocardiogram will wear the biostrap watch and then the PPG waveform will be obtained. Then, the ejection fraction will be collected from the echocardiogram report. Then, the Artificial Intelligence (AI) staff member will do a predictive model to try and estimate the EF based on the PPG waveform.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Photoplethysmography
Study Locations (3)
Louisiana
- East Jefferson General Hospital - New Orleans
- University Medical Center - New Orleans
- Tulane Doctors - Speciality Care - Napoleon - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-08-20 |
| Est. Completion | 2026-12 |
What NCT04843371 shows while recruiting
NCT04843371 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 606-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (17% lower).
The record links to 3 conditions, with Cardiomyopathies appearing as the primary indexed condition, and to 1 intervention - of which Photoplethysmography is the first listed.
NCT04843371 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT04843371 about?
NCT04843371 is a clinical study titled "PPG to Predict Ejection Fraction and Other Echographic Data in the General Population". The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signal...
What is the current status of trial NCT04843371?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2021-08-20. Estimated completion is 2026-12.
What conditions does trial NCT04843371 study?
This clinical trial studies the following conditions: Cardiomyopathies, Valvular Heart Disease, Pericardial Disease.
What interventions are being tested in trial NCT04843371?
The interventions under investigation include: Photoplethysmography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04843371?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04843371 being conducted?
This trial has 3 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiomyopathies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04843371's enrollment target sits among peer trials
500 6th of 17 higher than 12 of 17 other Cardiomyopathies trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiomyopathies trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cardiovascular Multimodality Imaging Study
RECRUITING
-
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
RECRUITING · Phase 1
-
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
RECRUITING · Phase 4
-
PKP2-ACM Natural History Study
RECRUITING
-
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
RECRUITING
-
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI